nodes	percent_of_prediction	percent_of_DWPC	metapath
Rocuronium—SLC22A1—hematologic cancer	0.426	1	CbGaD
Rocuronium—SLCO1A2—Chlorambucil—hematologic cancer	0.102	0.271	CbGbCtD
Rocuronium—SLC22A1—Cytarabine—hematologic cancer	0.0564	0.149	CbGbCtD
Rocuronium—SLC22A1—Cladribine—hematologic cancer	0.0532	0.141	CbGbCtD
Rocuronium—SLC22A1—Imatinib—hematologic cancer	0.0489	0.13	CbGbCtD
Rocuronium—SLCO1A2—Prednisolone—hematologic cancer	0.0387	0.103	CbGbCtD
Rocuronium—SLCO1A2—Prednisone—hematologic cancer	0.0366	0.0969	CbGbCtD
Rocuronium—SLCO1A2—Dexamethasone—hematologic cancer	0.0228	0.0605	CbGbCtD
Rocuronium—SLCO1A2—Methotrexate—hematologic cancer	0.0183	0.0486	CbGbCtD
Rocuronium—Vecuronium—SLC22A1—hematologic cancer	0.00164	0.467	CrCbGaD
Rocuronium—CHRNA1—hematopoietic system—hematologic cancer	0.00152	0.163	CbGeAlD
Rocuronium—Pancuronium—SLC22A1—hematologic cancer	0.0014	0.397	CrCbGaD
Rocuronium—CHRND—lung—hematologic cancer	0.00105	0.113	CbGeAlD
Rocuronium—HTR3A—hematopoietic system—hematologic cancer	0.000899	0.0967	CbGeAlD
Rocuronium—CHRNA2—blood—hematologic cancer	0.000833	0.0896	CbGeAlD
Rocuronium—CHRNB1—blood—hematologic cancer	0.000775	0.0834	CbGeAlD
Rocuronium—SLCO1A2—hematopoietic system—hematologic cancer	0.00071	0.0763	CbGeAlD
Rocuronium—CHRNB1—testis—hematologic cancer	0.000641	0.069	CbGeAlD
Rocuronium—HTR3A—blood—hematologic cancer	0.000596	0.064	CbGeAlD
Rocuronium—HTR3A—lung—hematologic cancer	0.000522	0.0561	CbGeAlD
Rocuronium—SLC22A1—blood—hematologic cancer	0.000488	0.0525	CbGeAlD
Rocuronium—Vecuronium—ABCB1—hematologic cancer	0.000478	0.136	CrCbGaD
Rocuronium—CHRNB1—lymph node—hematologic cancer	0.000465	0.05	CbGeAlD
Rocuronium—SLCO1A2—lung—hematologic cancer	0.000412	0.0443	CbGeAlD
Rocuronium—SLCO1A2—testis—hematologic cancer	0.000389	0.0418	CbGeAlD
Rocuronium—Hypersensitivity—Vinblastine—hematologic cancer	0.000204	0.00132	CcSEcCtD
Rocuronium—Vomiting—Bexarotene—hematologic cancer	0.000204	0.00131	CcSEcCtD
Rocuronium—Vomiting—Dasatinib—hematologic cancer	0.000204	0.00131	CcSEcCtD
Rocuronium—Muscular weakness—Prednisone—hematologic cancer	0.000203	0.00131	CcSEcCtD
Rocuronium—Vomiting—Fludarabine—hematologic cancer	0.000203	0.00131	CcSEcCtD
Rocuronium—Anaphylactic shock—Alitretinoin—hematologic cancer	0.000202	0.00131	CcSEcCtD
Rocuronium—Rash—Bexarotene—hematologic cancer	0.000202	0.0013	CcSEcCtD
Rocuronium—Rash—Dasatinib—hematologic cancer	0.000202	0.0013	CcSEcCtD
Rocuronium—Dermatitis—Bexarotene—hematologic cancer	0.000202	0.0013	CcSEcCtD
Rocuronium—Dermatitis—Dasatinib—hematologic cancer	0.000202	0.0013	CcSEcCtD
Rocuronium—Rash—Fludarabine—hematologic cancer	0.000201	0.0013	CcSEcCtD
Rocuronium—Dermatitis—Fludarabine—hematologic cancer	0.000201	0.0013	CcSEcCtD
Rocuronium—Hypertension—Irinotecan—hematologic cancer	0.000201	0.0013	CcSEcCtD
Rocuronium—Hypertension—Mitoxantrone—hematologic cancer	0.000201	0.0013	CcSEcCtD
Rocuronium—Anaphylactic shock—Ifosfamide—hematologic cancer	0.0002	0.00129	CcSEcCtD
Rocuronium—Nausea—Busulfan—hematologic cancer	0.0002	0.00129	CcSEcCtD
Rocuronium—Tachycardia—Carmustine—hematologic cancer	0.000199	0.00129	CcSEcCtD
Rocuronium—Shock—Alitretinoin—hematologic cancer	0.000199	0.00129	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Methotrexate—hematologic cancer	0.000199	0.00129	CcSEcCtD
Rocuronium—Hypotension—Thalidomide—hematologic cancer	0.000199	0.00128	CcSEcCtD
Rocuronium—Tachycardia—Alitretinoin—hematologic cancer	0.000198	0.00128	CcSEcCtD
Rocuronium—Arrhythmia—Prednisolone—hematologic cancer	0.000196	0.00127	CcSEcCtD
Rocuronium—Hypertension—Gemcitabine—hematologic cancer	0.000196	0.00126	CcSEcCtD
Rocuronium—Anaphylactic shock—Vincristine—hematologic cancer	0.000195	0.00126	CcSEcCtD
Rocuronium—Hypersensitivity—Melphalan—hematologic cancer	0.000194	0.00125	CcSEcCtD
Rocuronium—Nausea—Procarbazine—hematologic cancer	0.000194	0.00125	CcSEcCtD
Rocuronium—Vomiting—Chlorambucil—hematologic cancer	0.000192	0.00124	CcSEcCtD
Rocuronium—Hypotension—Carmustine—hematologic cancer	0.000191	0.00123	CcSEcCtD
Rocuronium—Nausea—Bexarotene—hematologic cancer	0.00019	0.00123	CcSEcCtD
Rocuronium—Nausea—Dasatinib—hematologic cancer	0.00019	0.00123	CcSEcCtD
Rocuronium—Anaphylactic shock—Irinotecan—hematologic cancer	0.00019	0.00123	CcSEcCtD
Rocuronium—Anaphylactic shock—Mitoxantrone—hematologic cancer	0.00019	0.00123	CcSEcCtD
Rocuronium—Nausea—Fludarabine—hematologic cancer	0.00019	0.00122	CcSEcCtD
Rocuronium—Hypotension—Alitretinoin—hematologic cancer	0.000189	0.00122	CcSEcCtD
Rocuronium—Hypersensitivity—Lenalidomide—hematologic cancer	0.000189	0.00122	CcSEcCtD
Rocuronium—Vomiting—Nilotinib—hematologic cancer	0.000188	0.00121	CcSEcCtD
Rocuronium—Vomiting—Imatinib—hematologic cancer	0.000187	0.00121	CcSEcCtD
Rocuronium—Hypotension—Ifosfamide—hematologic cancer	0.000187	0.00121	CcSEcCtD
Rocuronium—Shock—Irinotecan—hematologic cancer	0.000187	0.00121	CcSEcCtD
Rocuronium—Shock—Mitoxantrone—hematologic cancer	0.000187	0.00121	CcSEcCtD
Rocuronium—Pruritus—Melphalan—hematologic cancer	0.000186	0.0012	CcSEcCtD
Rocuronium—Rash—Nilotinib—hematologic cancer	0.000186	0.0012	CcSEcCtD
Rocuronium—Dermatitis—Nilotinib—hematologic cancer	0.000186	0.0012	CcSEcCtD
Rocuronium—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000186	0.0012	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Epirubicin—hematologic cancer	0.000186	0.0012	CcSEcCtD
Rocuronium—Rash—Imatinib—hematologic cancer	0.000185	0.0012	CcSEcCtD
Rocuronium—Tachycardia—Mitoxantrone—hematologic cancer	0.000185	0.0012	CcSEcCtD
Rocuronium—Dermatitis—Imatinib—hematologic cancer	0.000185	0.0012	CcSEcCtD
Rocuronium—Anaphylactic shock—Gemcitabine—hematologic cancer	0.000185	0.0012	CcSEcCtD
Rocuronium—Vomiting—Cladribine—hematologic cancer	0.000184	0.00119	CcSEcCtD
Rocuronium—Hypotension—Vincristine—hematologic cancer	0.000182	0.00118	CcSEcCtD
Rocuronium—Rash—Cladribine—hematologic cancer	0.000182	0.00118	CcSEcCtD
Rocuronium—Dermatitis—Cladribine—hematologic cancer	0.000182	0.00118	CcSEcCtD
Rocuronium—Pruritus—Lenalidomide—hematologic cancer	0.000181	0.00117	CcSEcCtD
Rocuronium—Arrhythmia—Triamcinolone—hematologic cancer	0.00018	0.00116	CcSEcCtD
Rocuronium—Nausea—Chlorambucil—hematologic cancer	0.00018	0.00116	CcSEcCtD
Rocuronium—Hypotension—Irinotecan—hematologic cancer	0.000177	0.00115	CcSEcCtD
Rocuronium—Hypotension—Mitoxantrone—hematologic cancer	0.000177	0.00115	CcSEcCtD
Rocuronium—Vomiting—Vinblastine—hematologic cancer	0.000176	0.00114	CcSEcCtD
Rocuronium—Nausea—Nilotinib—hematologic cancer	0.000176	0.00113	CcSEcCtD
Rocuronium—Nausea—Imatinib—hematologic cancer	0.000175	0.00113	CcSEcCtD
Rocuronium—Hypersensitivity—Bortezomib—hematologic cancer	0.000174	0.00112	CcSEcCtD
Rocuronium—Hypotension—Gemcitabine—hematologic cancer	0.000173	0.00112	CcSEcCtD
Rocuronium—Anaphylactic shock—Cisplatin—hematologic cancer	0.000172	0.00111	CcSEcCtD
Rocuronium—Hypersensitivity—Bleomycin—hematologic cancer	0.000172	0.00111	CcSEcCtD
Rocuronium—Anaphylactoid reaction—Doxorubicin—hematologic cancer	0.000172	0.00111	CcSEcCtD
Rocuronium—Nausea—Cladribine—hematologic cancer	0.000172	0.00111	CcSEcCtD
Rocuronium—Hypersensitivity—Vinorelbine—hematologic cancer	0.00017	0.0011	CcSEcCtD
Rocuronium—Tachycardia—Cisplatin—hematologic cancer	0.000168	0.00109	CcSEcCtD
Rocuronium—Vomiting—Melphalan—hematologic cancer	0.000168	0.00108	CcSEcCtD
Rocuronium—Hypertension—Etoposide—hematologic cancer	0.000167	0.00108	CcSEcCtD
Rocuronium—Pruritus—Bortezomib—hematologic cancer	0.000167	0.00108	CcSEcCtD
Rocuronium—Asthma—Methotrexate—hematologic cancer	0.000166	0.00107	CcSEcCtD
Rocuronium—Rash—Melphalan—hematologic cancer	0.000166	0.00107	CcSEcCtD
Rocuronium—Dermatitis—Melphalan—hematologic cancer	0.000166	0.00107	CcSEcCtD
Rocuronium—Pruritus—Bleomycin—hematologic cancer	0.000166	0.00107	CcSEcCtD
Rocuronium—Hypertension—Prednisolone—hematologic cancer	0.000165	0.00106	CcSEcCtD
Rocuronium—Nausea—Vinblastine—hematologic cancer	0.000165	0.00106	CcSEcCtD
Rocuronium—Arrhythmia—Betamethasone—hematologic cancer	0.000163	0.00106	CcSEcCtD
Rocuronium—Arrhythmia—Dexamethasone—hematologic cancer	0.000163	0.00106	CcSEcCtD
Rocuronium—Vomiting—Lenalidomide—hematologic cancer	0.000163	0.00105	CcSEcCtD
Rocuronium—Pruritus—Vinorelbine—hematologic cancer	0.000163	0.00105	CcSEcCtD
Rocuronium—Hypersensitivity—Thiotepa—hematologic cancer	0.000162	0.00105	CcSEcCtD
Rocuronium—Rash—Lenalidomide—hematologic cancer	0.000162	0.00104	CcSEcCtD
Rocuronium—Dermatitis—Lenalidomide—hematologic cancer	0.000161	0.00104	CcSEcCtD
Rocuronium—Hypotension—Cisplatin—hematologic cancer	0.000161	0.00104	CcSEcCtD
Rocuronium—Vomiting—Hydroxyurea—hematologic cancer	0.000161	0.00104	CcSEcCtD
Rocuronium—Rash—Hydroxyurea—hematologic cancer	0.000159	0.00103	CcSEcCtD
Rocuronium—Dermatitis—Hydroxyurea—hematologic cancer	0.000159	0.00103	CcSEcCtD
Rocuronium—Muscular weakness—Epirubicin—hematologic cancer	0.000159	0.00103	CcSEcCtD
Rocuronium—Anaphylactic shock—Etoposide—hematologic cancer	0.000158	0.00102	CcSEcCtD
Rocuronium—Hypersensitivity—Thalidomide—hematologic cancer	0.000157	0.00101	CcSEcCtD
Rocuronium—Nausea—Melphalan—hematologic cancer	0.000157	0.00101	CcSEcCtD
Rocuronium—Anaphylactic shock—Prednisolone—hematologic cancer	0.000156	0.00101	CcSEcCtD
Rocuronium—Asthma—Epirubicin—hematologic cancer	0.000156	0.00101	CcSEcCtD
Rocuronium—Pruritus—Thiotepa—hematologic cancer	0.000156	0.00101	CcSEcCtD
Rocuronium—Tachycardia—Etoposide—hematologic cancer	0.000154	0.000996	CcSEcCtD
Rocuronium—Shock—Prednisolone—hematologic cancer	0.000153	0.00099	CcSEcCtD
Rocuronium—Nausea—Lenalidomide—hematologic cancer	0.000152	0.000983	CcSEcCtD
Rocuronium—Tachycardia—Prednisolone—hematologic cancer	0.000152	0.000982	CcSEcCtD
Rocuronium—Hypertension—Triamcinolone—hematologic cancer	0.000152	0.000979	CcSEcCtD
Rocuronium—Hypersensitivity—Carmustine—hematologic cancer	0.000151	0.000972	CcSEcCtD
Rocuronium—Pruritus—Thalidomide—hematologic cancer	0.00015	0.000972	CcSEcCtD
Rocuronium—Nausea—Hydroxyurea—hematologic cancer	0.00015	0.00097	CcSEcCtD
Rocuronium—Vomiting—Bortezomib—hematologic cancer	0.00015	0.000969	CcSEcCtD
Rocuronium—Hypersensitivity—Alitretinoin—hematologic cancer	0.000149	0.000963	CcSEcCtD
Rocuronium—Vomiting—Bleomycin—hematologic cancer	0.000149	0.000961	CcSEcCtD
Rocuronium—Rash—Bortezomib—hematologic cancer	0.000149	0.000961	CcSEcCtD
Rocuronium—Dermatitis—Bortezomib—hematologic cancer	0.000149	0.00096	CcSEcCtD
Rocuronium—Hypotension—Etoposide—hematologic cancer	0.000148	0.000954	CcSEcCtD
Rocuronium—Rash—Bleomycin—hematologic cancer	0.000148	0.000953	CcSEcCtD
Rocuronium—Dermatitis—Bleomycin—hematologic cancer	0.000147	0.000952	CcSEcCtD
Rocuronium—Hypersensitivity—Ifosfamide—hematologic cancer	0.000147	0.000952	CcSEcCtD
Rocuronium—Muscular weakness—Doxorubicin—hematologic cancer	0.000147	0.00095	CcSEcCtD
Rocuronium—Vomiting—Vinorelbine—hematologic cancer	0.000146	0.000946	CcSEcCtD
Rocuronium—Rash—Vinorelbine—hematologic cancer	0.000145	0.000938	CcSEcCtD
Rocuronium—Dermatitis—Vinorelbine—hematologic cancer	0.000145	0.000937	CcSEcCtD
Rocuronium—Asthma—Doxorubicin—hematologic cancer	0.000144	0.000931	CcSEcCtD
Rocuronium—Hypersensitivity—Vincristine—hematologic cancer	0.000144	0.000928	CcSEcCtD
Rocuronium—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000143	0.000926	CcSEcCtD
Rocuronium—Pruritus—Alitretinoin—hematologic cancer	0.000143	0.000925	CcSEcCtD
Rocuronium—Arrhythmia—Prednisone—hematologic cancer	0.000142	0.00092	CcSEcCtD
Rocuronium—Pruritus—Ifosfamide—hematologic cancer	0.000142	0.000914	CcSEcCtD
Rocuronium—Shock—Triamcinolone—hematologic cancer	0.000141	0.000911	CcSEcCtD
Rocuronium—Nausea—Bortezomib—hematologic cancer	0.00014	0.000905	CcSEcCtD
Rocuronium—Hypersensitivity—Mitoxantrone—hematologic cancer	0.00014	0.000904	CcSEcCtD
Rocuronium—Hypersensitivity—Irinotecan—hematologic cancer	0.00014	0.000904	CcSEcCtD
Rocuronium—Tachycardia—Triamcinolone—hematologic cancer	0.00014	0.000903	CcSEcCtD
Rocuronium—Vomiting—Thiotepa—hematologic cancer	0.00014	0.000903	CcSEcCtD
Rocuronium—Nausea—Bleomycin—hematologic cancer	0.000139	0.000898	CcSEcCtD
Rocuronium—Rash—Thiotepa—hematologic cancer	0.000139	0.000896	CcSEcCtD
Rocuronium—Dermatitis—Thiotepa—hematologic cancer	0.000139	0.000895	CcSEcCtD
Rocuronium—Hypertension—Dexamethasone—hematologic cancer	0.000138	0.000889	CcSEcCtD
Rocuronium—Hypertension—Betamethasone—hematologic cancer	0.000138	0.000889	CcSEcCtD
Rocuronium—Nausea—Vinorelbine—hematologic cancer	0.000137	0.000884	CcSEcCtD
Rocuronium—Vomiting—Thalidomide—hematologic cancer	0.000135	0.000874	CcSEcCtD
Rocuronium—Rash—Thalidomide—hematologic cancer	0.000134	0.000866	CcSEcCtD
Rocuronium—Dermatitis—Thalidomide—hematologic cancer	0.000134	0.000866	CcSEcCtD
Rocuronium—Pruritus—Gemcitabine—hematologic cancer	0.000131	0.000846	CcSEcCtD
Rocuronium—Nausea—Thiotepa—hematologic cancer	0.000131	0.000844	CcSEcCtD
Rocuronium—Anaphylactic shock—Betamethasone—hematologic cancer	0.00013	0.00084	CcSEcCtD
Rocuronium—Anaphylactic shock—Dexamethasone—hematologic cancer	0.00013	0.00084	CcSEcCtD
Rocuronium—Vomiting—Carmustine—hematologic cancer	0.00013	0.000839	CcSEcCtD
Rocuronium—Rash—Carmustine—hematologic cancer	0.000129	0.000832	CcSEcCtD
Rocuronium—Dermatitis—Carmustine—hematologic cancer	0.000129	0.000831	CcSEcCtD
Rocuronium—Vomiting—Alitretinoin—hematologic cancer	0.000129	0.000831	CcSEcCtD
Rocuronium—Shock—Betamethasone—hematologic cancer	0.000128	0.000826	CcSEcCtD
Rocuronium—Shock—Dexamethasone—hematologic cancer	0.000128	0.000826	CcSEcCtD
Rocuronium—Rash—Alitretinoin—hematologic cancer	0.000128	0.000824	CcSEcCtD
Rocuronium—Dermatitis—Alitretinoin—hematologic cancer	0.000127	0.000824	CcSEcCtD
Rocuronium—Vomiting—Ifosfamide—hematologic cancer	0.000127	0.000822	CcSEcCtD
Rocuronium—Hypersensitivity—Cisplatin—hematologic cancer	0.000127	0.000821	CcSEcCtD
Rocuronium—Tachycardia—Dexamethasone—hematologic cancer	0.000127	0.00082	CcSEcCtD
Rocuronium—Tachycardia—Betamethasone—hematologic cancer	0.000127	0.00082	CcSEcCtD
Rocuronium—Nausea—Thalidomide—hematologic cancer	0.000126	0.000816	CcSEcCtD
Rocuronium—Rash—Ifosfamide—hematologic cancer	0.000126	0.000815	CcSEcCtD
Rocuronium—Dermatitis—Ifosfamide—hematologic cancer	0.000126	0.000814	CcSEcCtD
Rocuronium—Vomiting—Vincristine—hematologic cancer	0.000124	0.000801	CcSEcCtD
Rocuronium—Rash—Vincristine—hematologic cancer	0.000123	0.000794	CcSEcCtD
Rocuronium—Dermatitis—Vincristine—hematologic cancer	0.000123	0.000794	CcSEcCtD
Rocuronium—Hypotension—Dexamethasone—hematologic cancer	0.000121	0.000785	CcSEcCtD
Rocuronium—Hypotension—Betamethasone—hematologic cancer	0.000121	0.000785	CcSEcCtD
Rocuronium—Nausea—Carmustine—hematologic cancer	0.000121	0.000784	CcSEcCtD
Rocuronium—Vomiting—Mitoxantrone—hematologic cancer	0.000121	0.00078	CcSEcCtD
Rocuronium—Vomiting—Irinotecan—hematologic cancer	0.000121	0.00078	CcSEcCtD
Rocuronium—Nausea—Alitretinoin—hematologic cancer	0.00012	0.000777	CcSEcCtD
Rocuronium—Hypertension—Prednisone—hematologic cancer	0.00012	0.000774	CcSEcCtD
Rocuronium—Rash—Irinotecan—hematologic cancer	0.00012	0.000774	CcSEcCtD
Rocuronium—Rash—Mitoxantrone—hematologic cancer	0.00012	0.000774	CcSEcCtD
Rocuronium—Dermatitis—Mitoxantrone—hematologic cancer	0.00012	0.000773	CcSEcCtD
Rocuronium—Dermatitis—Irinotecan—hematologic cancer	0.00012	0.000773	CcSEcCtD
Rocuronium—Nausea—Ifosfamide—hematologic cancer	0.000119	0.000768	CcSEcCtD
Rocuronium—Vomiting—Gemcitabine—hematologic cancer	0.000118	0.00076	CcSEcCtD
Rocuronium—Rash—Gemcitabine—hematologic cancer	0.000117	0.000754	CcSEcCtD
Rocuronium—Dermatitis—Gemcitabine—hematologic cancer	0.000117	0.000753	CcSEcCtD
Rocuronium—Hypersensitivity—Etoposide—hematologic cancer	0.000116	0.000752	CcSEcCtD
Rocuronium—Nausea—Vincristine—hematologic cancer	0.000116	0.000748	CcSEcCtD
Rocuronium—Hypersensitivity—Prednisolone—hematologic cancer	0.000115	0.000742	CcSEcCtD
Rocuronium—Anaphylactic shock—Prednisone—hematologic cancer	0.000113	0.000731	CcSEcCtD
Rocuronium—Nausea—Irinotecan—hematologic cancer	0.000113	0.000729	CcSEcCtD
Rocuronium—Nausea—Mitoxantrone—hematologic cancer	0.000113	0.000729	CcSEcCtD
Rocuronium—Pruritus—Etoposide—hematologic cancer	0.000112	0.000722	CcSEcCtD
Rocuronium—Shock—Prednisone—hematologic cancer	0.000111	0.00072	CcSEcCtD
Rocuronium—Arrhythmia—Epirubicin—hematologic cancer	0.000111	0.000719	CcSEcCtD
Rocuronium—Tachycardia—Prednisone—hematologic cancer	0.000111	0.000714	CcSEcCtD
Rocuronium—Nausea—Gemcitabine—hematologic cancer	0.00011	0.00071	CcSEcCtD
Rocuronium—Vomiting—Cisplatin—hematologic cancer	0.00011	0.000708	CcSEcCtD
Rocuronium—Rash—Cisplatin—hematologic cancer	0.000109	0.000702	CcSEcCtD
Rocuronium—Dermatitis—Cisplatin—hematologic cancer	0.000109	0.000702	CcSEcCtD
Rocuronium—Hypersensitivity—Triamcinolone—hematologic cancer	0.000106	0.000682	CcSEcCtD
Rocuronium—Arrhythmia—Doxorubicin—hematologic cancer	0.000103	0.000666	CcSEcCtD
Rocuronium—Nausea—Cisplatin—hematologic cancer	0.000102	0.000662	CcSEcCtD
Rocuronium—Pruritus—Triamcinolone—hematologic cancer	0.000101	0.000655	CcSEcCtD
Rocuronium—Vomiting—Etoposide—hematologic cancer	0.0001	0.000649	CcSEcCtD
Rocuronium—Rash—Etoposide—hematologic cancer	9.96e-05	0.000643	CcSEcCtD
Rocuronium—Dermatitis—Etoposide—hematologic cancer	9.95e-05	0.000643	CcSEcCtD
Rocuronium—Rash—Prednisolone—hematologic cancer	9.82e-05	0.000635	CcSEcCtD
Rocuronium—Dermatitis—Prednisolone—hematologic cancer	9.82e-05	0.000634	CcSEcCtD
Rocuronium—Anaphylactic shock—Methotrexate—hematologic cancer	9.46e-05	0.000611	CcSEcCtD
Rocuronium—Nausea—Etoposide—hematologic cancer	9.38e-05	0.000606	CcSEcCtD
Rocuronium—Hypertension—Epirubicin—hematologic cancer	9.37e-05	0.000605	CcSEcCtD
Rocuronium—Nausea—Prednisolone—hematologic cancer	9.26e-05	0.000598	CcSEcCtD
Rocuronium—Pruritus—Betamethasone—hematologic cancer	9.2e-05	0.000594	CcSEcCtD
Rocuronium—Pruritus—Dexamethasone—hematologic cancer	9.2e-05	0.000594	CcSEcCtD
Rocuronium—Vomiting—Triamcinolone—hematologic cancer	9.11e-05	0.000589	CcSEcCtD
Rocuronium—Rash—Triamcinolone—hematologic cancer	9.03e-05	0.000584	CcSEcCtD
Rocuronium—Dermatitis—Triamcinolone—hematologic cancer	9.03e-05	0.000583	CcSEcCtD
Rocuronium—Anaphylactic shock—Epirubicin—hematologic cancer	8.86e-05	0.000572	CcSEcCtD
Rocuronium—Hypotension—Methotrexate—hematologic cancer	8.84e-05	0.000571	CcSEcCtD
Rocuronium—Shock—Epirubicin—hematologic cancer	8.71e-05	0.000563	CcSEcCtD
Rocuronium—Hypertension—Doxorubicin—hematologic cancer	8.67e-05	0.00056	CcSEcCtD
Rocuronium—Tachycardia—Epirubicin—hematologic cancer	8.64e-05	0.000558	CcSEcCtD
Rocuronium—Nausea—Triamcinolone—hematologic cancer	8.51e-05	0.00055	CcSEcCtD
Rocuronium—Hypersensitivity—Prednisone—hematologic cancer	8.34e-05	0.000539	CcSEcCtD
Rocuronium—Hypotension—Epirubicin—hematologic cancer	8.27e-05	0.000535	CcSEcCtD
Rocuronium—Vomiting—Dexamethasone—hematologic cancer	8.27e-05	0.000534	CcSEcCtD
Rocuronium—Vomiting—Betamethasone—hematologic cancer	8.27e-05	0.000534	CcSEcCtD
Rocuronium—Rash—Betamethasone—hematologic cancer	8.2e-05	0.00053	CcSEcCtD
Rocuronium—Rash—Dexamethasone—hematologic cancer	8.2e-05	0.00053	CcSEcCtD
Rocuronium—Anaphylactic shock—Doxorubicin—hematologic cancer	8.19e-05	0.000529	CcSEcCtD
Rocuronium—Dermatitis—Dexamethasone—hematologic cancer	8.19e-05	0.000529	CcSEcCtD
Rocuronium—Dermatitis—Betamethasone—hematologic cancer	8.19e-05	0.000529	CcSEcCtD
Rocuronium—Shock—Doxorubicin—hematologic cancer	8.06e-05	0.000521	CcSEcCtD
Rocuronium—Pruritus—Prednisone—hematologic cancer	8.01e-05	0.000518	CcSEcCtD
Rocuronium—Tachycardia—Doxorubicin—hematologic cancer	8e-05	0.000517	CcSEcCtD
Rocuronium—Nausea—Dexamethasone—hematologic cancer	7.72e-05	0.000499	CcSEcCtD
Rocuronium—Nausea—Betamethasone—hematologic cancer	7.72e-05	0.000499	CcSEcCtD
Rocuronium—Hypotension—Doxorubicin—hematologic cancer	7.66e-05	0.000495	CcSEcCtD
Rocuronium—Vomiting—Prednisone—hematologic cancer	7.2e-05	0.000465	CcSEcCtD
Rocuronium—Rash—Prednisone—hematologic cancer	7.14e-05	0.000461	CcSEcCtD
Rocuronium—Dermatitis—Prednisone—hematologic cancer	7.13e-05	0.000461	CcSEcCtD
Rocuronium—Hypersensitivity—Methotrexate—hematologic cancer	6.97e-05	0.00045	CcSEcCtD
Rocuronium—Nausea—Prednisone—hematologic cancer	6.73e-05	0.000434	CcSEcCtD
Rocuronium—Pruritus—Methotrexate—hematologic cancer	6.69e-05	0.000432	CcSEcCtD
Rocuronium—Hypersensitivity—Epirubicin—hematologic cancer	6.52e-05	0.000421	CcSEcCtD
Rocuronium—Pruritus—Epirubicin—hematologic cancer	6.27e-05	0.000405	CcSEcCtD
Rocuronium—Hypersensitivity—Doxorubicin—hematologic cancer	6.04e-05	0.00039	CcSEcCtD
Rocuronium—Vomiting—Methotrexate—hematologic cancer	6.02e-05	0.000389	CcSEcCtD
Rocuronium—Rash—Methotrexate—hematologic cancer	5.97e-05	0.000385	CcSEcCtD
Rocuronium—Dermatitis—Methotrexate—hematologic cancer	5.96e-05	0.000385	CcSEcCtD
Rocuronium—Pruritus—Doxorubicin—hematologic cancer	5.8e-05	0.000375	CcSEcCtD
Rocuronium—Vomiting—Epirubicin—hematologic cancer	5.63e-05	0.000364	CcSEcCtD
Rocuronium—Nausea—Methotrexate—hematologic cancer	5.62e-05	0.000363	CcSEcCtD
Rocuronium—Rash—Epirubicin—hematologic cancer	5.58e-05	0.000361	CcSEcCtD
Rocuronium—Dermatitis—Epirubicin—hematologic cancer	5.58e-05	0.00036	CcSEcCtD
Rocuronium—Nausea—Epirubicin—hematologic cancer	5.26e-05	0.00034	CcSEcCtD
Rocuronium—Vomiting—Doxorubicin—hematologic cancer	5.21e-05	0.000337	CcSEcCtD
Rocuronium—Rash—Doxorubicin—hematologic cancer	5.17e-05	0.000334	CcSEcCtD
Rocuronium—Dermatitis—Doxorubicin—hematologic cancer	5.16e-05	0.000333	CcSEcCtD
Rocuronium—Nausea—Doxorubicin—hematologic cancer	4.87e-05	0.000314	CcSEcCtD
Rocuronium—SLCO1A2—Metabolism—ABCG2—hematologic cancer	1.29e-05	0.00045	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ARNTL—hematologic cancer	1.28e-05	0.000446	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ENO2—hematologic cancer	1.27e-05	0.000441	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—TNF—hematologic cancer	1.26e-05	0.000438	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.26e-05	0.000438	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGEF12—hematologic cancer	1.26e-05	0.000438	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—ADCY7—hematologic cancer	1.26e-05	0.000437	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PTHLH—hematologic cancer	1.25e-05	0.000436	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ACP5—hematologic cancer	1.25e-05	0.000434	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CA9—hematologic cancer	1.25e-05	0.000434	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOR2—hematologic cancer	1.23e-05	0.000428	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTT1—hematologic cancer	1.23e-05	0.000428	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ARHGEF1—hematologic cancer	1.22e-05	0.000426	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PTGER4—hematologic cancer	1.22e-05	0.000424	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.21e-05	0.000421	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—SDC1—hematologic cancer	1.2e-05	0.000418	CbGpPWpGaD
Rocuronium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—hematologic cancer	1.19e-05	0.000414	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—IDH1—hematologic cancer	1.17e-05	0.000408	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCC3—hematologic cancer	1.16e-05	0.000403	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTO1—hematologic cancer	1.16e-05	0.000403	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—TXN—hematologic cancer	1.16e-05	0.000403	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.15e-05	0.000401	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL3—hematologic cancer	1.15e-05	0.0004	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.15e-05	0.000399	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTHLH—hematologic cancer	1.14e-05	0.000396	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SPHK1—hematologic cancer	1.13e-05	0.000394	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.13e-05	0.000394	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTGER4—hematologic cancer	1.11e-05	0.000385	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL17—hematologic cancer	1.1e-05	0.000382	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGRN—hematologic cancer	1.1e-05	0.000382	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—UGT1A1—hematologic cancer	1.09e-05	0.000379	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.08e-05	0.000377	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCR5—hematologic cancer	1.08e-05	0.000375	CbGpPWpGaD
Rocuronium—SLCO1A2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.08e-05	0.000375	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CXCR4—hematologic cancer	1.08e-05	0.000375	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LEF1—hematologic cancer	1.06e-05	0.000369	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CRABP1—hematologic cancer	1.06e-05	0.000369	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GNA13—hematologic cancer	1.04e-05	0.000363	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL3—hematologic cancer	1.04e-05	0.000361	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALOX5—hematologic cancer	1.03e-05	0.000359	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TIAM1—hematologic cancer	1.02e-05	0.000357	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NQO1—hematologic cancer	1.02e-05	0.000356	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CD44—hematologic cancer	1.02e-05	0.000356	CbGpPWpGaD
Rocuronium—CHRM2—SIDS Susceptibility Pathways—IL6—hematologic cancer	1.02e-05	0.000354	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—RASGRP1—hematologic cancer	1e-05	0.000349	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1e-05	0.000348	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NUP98—hematologic cancer	9.99e-06	0.000348	CbGpPWpGaD
Rocuronium—CHRM2—GPCR ligand binding—CCL2—hematologic cancer	9.98e-06	0.000347	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAK3—hematologic cancer	9.93e-06	0.000346	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CXCR4—hematologic cancer	9.77e-06	0.00034	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ADCY7—hematologic cancer	9.7e-06	0.000338	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOA3—hematologic cancer	9.7e-06	0.000338	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CYCS—hematologic cancer	9.66e-06	0.000336	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NUP214—hematologic cancer	9.63e-06	0.000335	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—HSP90AA1—hematologic cancer	9.6e-06	0.000334	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCR7—hematologic cancer	9.52e-06	0.000332	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCL13—hematologic cancer	9.52e-06	0.000332	CbGpPWpGaD
Rocuronium—SLC22A1—Transmission across Chemical Synapses—HRAS—hematologic cancer	9.51e-06	0.000331	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCG2—hematologic cancer	9.44e-06	0.000329	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTR—hematologic cancer	9.44e-06	0.000329	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL3—hematologic cancer	9.42e-06	0.000328	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCOR2—hematologic cancer	9.4e-06	0.000327	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL3RA—hematologic cancer	9.28e-06	0.000323	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CRKL—hematologic cancer	9.28e-06	0.000323	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ENO2—hematologic cancer	9.25e-06	0.000322	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—RASGRP1—hematologic cancer	9.11e-06	0.000317	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—GRB2—hematologic cancer	9.02e-06	0.000314	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTT1—hematologic cancer	8.98e-06	0.000313	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RGS2—hematologic cancer	8.95e-06	0.000312	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CMA1—hematologic cancer	8.85e-06	0.000308	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TRH—hematologic cancer	8.85e-06	0.000308	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TRIO—hematologic cancer	8.85e-06	0.000308	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—SDC1—hematologic cancer	8.77e-06	0.000305	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AGO2—hematologic cancer	8.66e-06	0.000302	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SPHK1—hematologic cancer	8.66e-06	0.000302	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	8.64e-06	0.000301	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HDAC9—hematologic cancer	8.58e-06	0.000299	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LPAR1—hematologic cancer	8.58e-06	0.000299	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTP1—hematologic cancer	8.52e-06	0.000297	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—H3F3B—hematologic cancer	8.49e-06	0.000296	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.4e-06	0.000293	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.24e-06	0.000287	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—GRB2—hematologic cancer	8.19e-06	0.000285	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ABCB1—hematologic cancer	8.06e-06	0.000281	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—CSF2—hematologic cancer	8.06e-06	0.000281	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDE4B—hematologic cancer	7.89e-06	0.000275	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CNR2—hematologic cancer	7.89e-06	0.000275	CbGpPWpGaD
Rocuronium—SLC22A1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.87e-06	0.000274	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—GSTM1—hematologic cancer	7.83e-06	0.000273	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—NCOR1—hematologic cancer	7.83e-06	0.000273	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF19—hematologic cancer	7.83e-06	0.000273	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PRKCG—hematologic cancer	7.78e-06	0.000271	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—JAK1—hematologic cancer	7.78e-06	0.000271	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RAC2—hematologic cancer	7.76e-06	0.00027	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—DKK1—hematologic cancer	7.7e-06	0.000268	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT5B—hematologic cancer	7.64e-06	0.000266	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NQO1—hematologic cancer	7.46e-06	0.00026	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CD44—hematologic cancer	7.46e-06	0.00026	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ADCY7—hematologic cancer	7.42e-06	0.000258	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CSF2—hematologic cancer	7.32e-06	0.000255	CbGpPWpGaD
Rocuronium—SLC22A1—Neuronal System—HRAS—hematologic cancer	7.29e-06	0.000254	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL2RA—hematologic cancer	7.27e-06	0.000253	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—XIAP—hematologic cancer	7.22e-06	0.000251	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PRKCG—hematologic cancer	7.07e-06	0.000246	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—JAK1—hematologic cancer	7.07e-06	0.000246	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CYCS—hematologic cancer	7.06e-06	0.000246	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SH2B3—hematologic cancer	7.03e-06	0.000245	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SMARCA4—hematologic cancer	7.03e-06	0.000245	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—HSP90AA1—hematologic cancer	7.01e-06	0.000244	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GZMB—hematologic cancer	6.99e-06	0.000243	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—MTHFR—hematologic cancer	6.92e-06	0.000241	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CTNNA1—hematologic cancer	6.83e-06	0.000238	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EIF4EBP1—hematologic cancer	6.79e-06	0.000236	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HSPB1—hematologic cancer	6.79e-06	0.000236	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL3—hematologic cancer	6.79e-06	0.000236	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTHLH—hematologic cancer	6.71e-06	0.000234	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SDC1—hematologic cancer	6.71e-06	0.000234	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL2RA—hematologic cancer	6.6e-06	0.00023	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTGER4—hematologic cancer	6.53e-06	0.000227	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—LCK—hematologic cancer	6.5e-06	0.000226	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—H3F3A—hematologic cancer	6.37e-06	0.000222	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTP1—hematologic cancer	6.22e-06	0.000217	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKCZ—hematologic cancer	6.19e-06	0.000216	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.1e-06	0.000212	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CG—hematologic cancer	6.05e-06	0.000211	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PARP1—hematologic cancer	5.98e-06	0.000208	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ABCB1—hematologic cancer	5.89e-06	0.000205	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FBXW7—hematologic cancer	5.88e-06	0.000205	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	5.81e-06	0.000202	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CXCR4—hematologic cancer	5.77e-06	0.000201	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HDAC2—hematologic cancer	5.77e-06	0.000201	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—NCOR1—hematologic cancer	5.72e-06	0.000199	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—GSTM1—hematologic cancer	5.72e-06	0.000199	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CBL—hematologic cancer	5.62e-06	0.000196	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL3—hematologic cancer	5.56e-06	0.000194	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CG—hematologic cancer	5.5e-06	0.000191	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTPN1—hematologic cancer	5.47e-06	0.00019	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PTPN11—hematologic cancer	5.4e-06	0.000188	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—CREBBP—hematologic cancer	5.39e-06	0.000188	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—RASGRP1—hematologic cancer	5.38e-06	0.000187	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SYK—hematologic cancer	5.36e-06	0.000187	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HSP90AA1—hematologic cancer	5.36e-06	0.000187	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CD—hematologic cancer	5.32e-06	0.000185	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CREB1—hematologic cancer	5.23e-06	0.000182	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT1—hematologic cancer	5.17e-06	0.00018	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—CCL2—hematologic cancer	5.12e-06	0.000178	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	5.11e-06	0.000178	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6R—hematologic cancer	5.1e-06	0.000178	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—MTHFR—hematologic cancer	5.05e-06	0.000176	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—ALB—hematologic cancer	5.04e-06	0.000176	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3R1—hematologic cancer	5.02e-06	0.000175	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—JAK2—hematologic cancer	4.88e-06	0.00017	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MAP2K1—hematologic cancer	4.86e-06	0.000169	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—GRB2—hematologic cancer	4.84e-06	0.000169	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CD—hematologic cancer	4.83e-06	0.000168	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFA—hematologic cancer	4.83e-06	0.000168	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	4.82e-06	0.000168	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KITLG—hematologic cancer	4.76e-06	0.000166	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT5A—hematologic cancer	4.65e-06	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CB—hematologic cancer	4.64e-06	0.000162	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN2B—hematologic cancer	4.61e-06	0.000161	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3R1—hematologic cancer	4.56e-06	0.000159	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CD86—hematologic cancer	4.46e-06	0.000155	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	4.45e-06	0.000155	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—JAK2—hematologic cancer	4.43e-06	0.000154	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HES1—hematologic cancer	4.4e-06	0.000153	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NCOR1—hematologic cancer	4.37e-06	0.000152	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CSF2—hematologic cancer	4.32e-06	0.000151	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF1—hematologic cancer	4.32e-06	0.000151	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FOXO1—hematologic cancer	4.26e-06	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—IL2—hematologic cancer	4.26e-06	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFRB—hematologic cancer	4.25e-06	0.000148	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CG—hematologic cancer	4.25e-06	0.000148	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CB—hematologic cancer	4.21e-06	0.000147	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFRA—hematologic cancer	4.19e-06	0.000146	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAK1—hematologic cancer	4.17e-06	0.000145	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PRKCG—hematologic cancer	4.17e-06	0.000145	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—CREBBP—hematologic cancer	3.94e-06	0.000137	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL2RA—hematologic cancer	3.9e-06	0.000136	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL2—hematologic cancer	3.87e-06	0.000135	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TERT—hematologic cancer	3.85e-06	0.000134	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PTEN—hematologic cancer	3.85e-06	0.000134	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PDGFB—hematologic cancer	3.76e-06	0.000131	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CD—hematologic cancer	3.73e-06	0.00013	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—ALB—hematologic cancer	3.68e-06	0.000128	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TSC2—hematologic cancer	3.68e-06	0.000128	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—EP300—hematologic cancer	3.67e-06	0.000128	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGFR3—hematologic cancer	3.54e-06	0.000123	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3R1—hematologic cancer	3.52e-06	0.000123	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK14—hematologic cancer	3.5e-06	0.000122	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—ESR1—hematologic cancer	3.44e-06	0.00012	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FN1—hematologic cancer	3.39e-06	0.000118	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BAD—hematologic cancer	3.35e-06	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NFKBIA—hematologic cancer	3.35e-06	0.000117	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NOTCH1—hematologic cancer	3.32e-06	0.000116	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CD80—hematologic cancer	3.25e-06	0.000113	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CB—hematologic cancer	3.25e-06	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CG—hematologic cancer	3.25e-06	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KIT—hematologic cancer	3.25e-06	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—NRAS—hematologic cancer	3.25e-06	0.000113	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTPN11—hematologic cancer	3.19e-06	0.000111	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—MAPK3—hematologic cancer	3.11e-06	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CREB1—hematologic cancer	3.09e-06	0.000108	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—BRAF—hematologic cancer	3.05e-06	0.000106	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCL2—hematologic cancer	3.02e-06	0.000105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6R—hematologic cancer	3.02e-06	0.000105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CREBBP—hematologic cancer	3.01e-06	0.000105	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAP2K1—hematologic cancer	2.87e-06	0.0001	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CD—hematologic cancer	2.85e-06	9.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.83e-06	9.85e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PTEN—hematologic cancer	2.81e-06	9.79e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—KRAS—hematologic cancer	2.79e-06	9.73e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—FGF2—hematologic cancer	2.73e-06	9.52e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	2.71e-06	9.45e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3R1—hematologic cancer	2.7e-06	9.39e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—EP300—hematologic cancer	2.68e-06	9.33e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JAK2—hematologic cancer	2.62e-06	9.12e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—PIK3CA—hematologic cancer	2.57e-06	8.94e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MDM2—hematologic cancer	2.56e-06	8.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MTOR—hematologic cancer	2.49e-06	8.66e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CB—hematologic cancer	2.49e-06	8.66e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—HRAS—hematologic cancer	2.38e-06	8.27e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN1B—hematologic cancer	2.34e-06	8.13e-05	CbGpPWpGaD
Rocuronium—CHRM2—GPCR downstream signaling—AKT1—hematologic cancer	2.31e-06	8.04e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CASP3—hematologic cancer	2.29e-06	7.97e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL2—hematologic cancer	2.29e-06	7.96e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—IL6—hematologic cancer	2.27e-06	7.92e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CCND1—hematologic cancer	2.23e-06	7.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—JUN—hematologic cancer	2.22e-06	7.74e-05	CbGpPWpGaD
Rocuronium—SLCO1A2—Metabolism—AKT1—hematologic cancer	2.22e-06	7.72e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—CDKN1A—hematologic cancer	2.15e-06	7.5e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PTEN—hematologic cancer	2.15e-06	7.49e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK8—hematologic cancer	2.1e-06	7.32e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling by GPCR—AKT1—hematologic cancer	2.1e-06	7.3e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—EP300—hematologic cancer	2.05e-06	7.14e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—SRC—hematologic cancer	1.99e-06	6.94e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.98e-06	6.9e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—VEGFA—hematologic cancer	1.94e-06	6.76e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—STAT3—hematologic cancer	1.92e-06	6.7e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—NRAS—hematologic cancer	1.92e-06	6.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MAPK3—hematologic cancer	1.84e-06	6.4e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—MYC—hematologic cancer	1.79e-06	6.22e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TGFB1—hematologic cancer	1.78e-06	6.21e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—KRAS—hematologic cancer	1.65e-06	5.75e-05	CbGpPWpGaD
Rocuronium—SLC22A1—Metabolism—AKT1—hematologic cancer	1.62e-06	5.64e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—PIK3CA—hematologic cancer	1.52e-06	5.28e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—TP53—hematologic cancer	1.47e-06	5.11e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—HRAS—hematologic cancer	1.4e-06	4.89e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—IL6—hematologic cancer	1.34e-06	4.68e-05	CbGpPWpGaD
Rocuronium—CHRM2—Signaling Pathways—AKT1—hematologic cancer	1.24e-06	4.31e-05	CbGpPWpGaD
